Evaluation of Medication Use in Malaysian Predialysis Patients

Chronic kidney disease (CKD) patients suffer from multiple comorbidities and complications as a cause or consequence of kidney disease. Information regarding medicationprescribing patterns in predialysis patients is sparse. We conducted a retrospective study to evaluate the medication prescriptio...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammad Salman, Muhammad Salman, Khan, Amer Hayat, Adnan, Azreen Syazril, Syed Sulaiman, Syed Azhar, Shehzadi, Naureen, Asif, Nauman, Hussain, Khalid, Saleem, Fahad, Raza, Muhammed Hussnain, Farooq, Muhammad Shahid
Format: Article
Language:English
Published: Medknow Publications 2017
Subjects:
Online Access:http://eprints.usm.my/36928/1/%28Evaluation_of_medication_use%29_SaudiJKidneyDisTranspl283517-7557673_205936.pdf
http://eprints.usm.my/36928/
http://www.sjkdt.org/text.asp?2017/28/3/517/206451
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.usm.eprints.36928
record_format eprints
spelling my.usm.eprints.36928 http://eprints.usm.my/36928/ Evaluation of Medication Use in Malaysian Predialysis Patients Muhammad Salman, Muhammad Salman Khan, Amer Hayat Adnan, Azreen Syazril Syed Sulaiman, Syed Azhar Shehzadi, Naureen Asif, Nauman Hussain, Khalid Saleem, Fahad Raza, Muhammed Hussnain Farooq, Muhammad Shahid R Medicine (General) RS Pharmacy and materia medica Chronic kidney disease (CKD) patients suffer from multiple comorbidities and complications as a cause or consequence of kidney disease. Information regarding medicationprescribing patterns in predialysis patients is sparse. We conducted a retrospective study to evaluate the medication prescription patterns among predialysis patients. Medical records (both paper based and computerized) of patients at CKD Resource Centre, Hospital Universiti Sains Malaysia, were reviewed. A total of 615 eligible cases were included in the study. The mean number of medications prescribed per patient was 8.22 ± 2.81, and medication use was correlated to the renal function (stage 3a < stage 3b < stage 4 < stage 5; P <0.001). The top three prescribed medication groups were found to be lipid-lowering agents, calcium channel blockers, and antiplatelet agents. Some medication classes such as nonaluminum/noncalcium phosphate binders, erythropoietin-stimulating agents, and renin-angiotensin-aldosterone system blockers, particularly in advanced stage, were found to be underutilized. In conclusion, predialysis patients are prescribed a large number of medications. Our findings highlight the need for assessing the impact of current medication-prescribing patterns on morbidity and mortality rates in Malaysian predialysis population. Medknow Publications 2017 Article PeerReviewed application/pdf en http://eprints.usm.my/36928/1/%28Evaluation_of_medication_use%29_SaudiJKidneyDisTranspl283517-7557673_205936.pdf Muhammad Salman, Muhammad Salman and Khan, Amer Hayat and Adnan, Azreen Syazril and Syed Sulaiman, Syed Azhar and Shehzadi, Naureen and Asif, Nauman and Hussain, Khalid and Saleem, Fahad and Raza, Muhammed Hussnain and Farooq, Muhammad Shahid (2017) Evaluation of Medication Use in Malaysian Predialysis Patients. Saudi Journal of Kidney Diseases and Transplantation, 28 (3). pp. 517-523. ISSN 1319-2442 http://www.sjkdt.org/text.asp?2017/28/3/517/206451
institution Universiti Sains Malaysia
building Hamzah Sendut Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
url_provider http://eprints.usm.my/
language English
topic R Medicine (General)
RS Pharmacy and materia medica
spellingShingle R Medicine (General)
RS Pharmacy and materia medica
Muhammad Salman, Muhammad Salman
Khan, Amer Hayat
Adnan, Azreen Syazril
Syed Sulaiman, Syed Azhar
Shehzadi, Naureen
Asif, Nauman
Hussain, Khalid
Saleem, Fahad
Raza, Muhammed Hussnain
Farooq, Muhammad Shahid
Evaluation of Medication Use in Malaysian Predialysis Patients
description Chronic kidney disease (CKD) patients suffer from multiple comorbidities and complications as a cause or consequence of kidney disease. Information regarding medicationprescribing patterns in predialysis patients is sparse. We conducted a retrospective study to evaluate the medication prescription patterns among predialysis patients. Medical records (both paper based and computerized) of patients at CKD Resource Centre, Hospital Universiti Sains Malaysia, were reviewed. A total of 615 eligible cases were included in the study. The mean number of medications prescribed per patient was 8.22 ± 2.81, and medication use was correlated to the renal function (stage 3a < stage 3b < stage 4 < stage 5; P <0.001). The top three prescribed medication groups were found to be lipid-lowering agents, calcium channel blockers, and antiplatelet agents. Some medication classes such as nonaluminum/noncalcium phosphate binders, erythropoietin-stimulating agents, and renin-angiotensin-aldosterone system blockers, particularly in advanced stage, were found to be underutilized. In conclusion, predialysis patients are prescribed a large number of medications. Our findings highlight the need for assessing the impact of current medication-prescribing patterns on morbidity and mortality rates in Malaysian predialysis population.
format Article
author Muhammad Salman, Muhammad Salman
Khan, Amer Hayat
Adnan, Azreen Syazril
Syed Sulaiman, Syed Azhar
Shehzadi, Naureen
Asif, Nauman
Hussain, Khalid
Saleem, Fahad
Raza, Muhammed Hussnain
Farooq, Muhammad Shahid
author_facet Muhammad Salman, Muhammad Salman
Khan, Amer Hayat
Adnan, Azreen Syazril
Syed Sulaiman, Syed Azhar
Shehzadi, Naureen
Asif, Nauman
Hussain, Khalid
Saleem, Fahad
Raza, Muhammed Hussnain
Farooq, Muhammad Shahid
author_sort Muhammad Salman, Muhammad Salman
title Evaluation of Medication Use in Malaysian Predialysis Patients
title_short Evaluation of Medication Use in Malaysian Predialysis Patients
title_full Evaluation of Medication Use in Malaysian Predialysis Patients
title_fullStr Evaluation of Medication Use in Malaysian Predialysis Patients
title_full_unstemmed Evaluation of Medication Use in Malaysian Predialysis Patients
title_sort evaluation of medication use in malaysian predialysis patients
publisher Medknow Publications
publishDate 2017
url http://eprints.usm.my/36928/1/%28Evaluation_of_medication_use%29_SaudiJKidneyDisTranspl283517-7557673_205936.pdf
http://eprints.usm.my/36928/
http://www.sjkdt.org/text.asp?2017/28/3/517/206451
_version_ 1643708925344743424
score 13.211869